ACTA1 and metabolic dysfunction-associated steatotic liver disease: cDNT transfer significantly decreased the NAFLD activity score (NAS), and the staining of Sirius red and α-smooth muscle actin (α-SMA), downregulated hepatic hydroxyproline content levels in HFD-fed mice (Fig. 1j–l).